21.02.2019
A new scientific paper published in the Journal of Clinical Monitoring and Computing
The Journal of Clinical Monitoring and Computing has just published on the EEG-based assessment of brain function after cardiac arrest.
our study
https://link.springer.com/article/10.1007%2Fs10877-019-00282-3
The findings of the study show that forehead electrodes are sufficient in detecting propofol-induced slow waves thus offering potential in the development of a clinically practical method for the monitoring of brain function in comatose cardiac arrest survivors.
"These results further strengthen the scientific foundation of our C-Trend technology", says Dr. Jukka Kortelainen, Chief Medical Officer of Cerenion and corresponding author of the publication. "We have previously shown that the existence of slow waves in the EEG after cardiac arrest is associated with good neurological recovery. C-Trend technology is based on the measurement of these waves. The results of the current study suggest that slow waves can be detected using a reduced electrode set located in the forehead area. Using this kind of an electrode set can tremendously ease the recording in the demanding intensive care environment", he continues.
The work was a joint-effort between Cerenion, Oulu University Hospital, and the University of Oulu.
The Journal of Clinical Monitoring and Computing, published by Springer, is a clinical journal publishing papers related to technology in the fields of anaesthesia, intensive care medicine, emergency medicine, and peri-operative medicine.
Highlights
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Not available in the United States. Cerenion™, Cerenion C-Trend™, C-Trend™, "The next-generation brain monitoring company"™ and "The pulse of the brain"™ are registered trademarks and/or trademarks of Cerenion Oy. Cerenion C-Trend™ is intended for use by qualified medical practitioners who will exercise professional judgment in its use. Cerenion technology is protected by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2020.